GPRI
Groningen, Netherlands
Research institute in Groningen
Professor Enno Dirk Wiersmastraat 5, 9713 GH Groningen
About GPRI
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
General Practitioners Research Institute
4
Eli Lilly and Company
1
Valneva Austria GmbH
1
Clinical Trials at GPRI
During the past decade, GPRI conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study
2021-02-16
2021-04-23
Terminated
17
VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection
2022-05-09
2023-05-14
Active, not recruiting
275
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
2022-10-11
2027-10-07
Recruiting
15,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "GPRI"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Huisartsenzorg Drenthe" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at GPRI
According to Clinical.Site data, the most researched conditions in "GPRI" are
"Asthma" (1 trials), "Asthma Chronic" (1 trials), "Asthma; Eosinophilic" (1 trials), "Asthma; Status" (1 trials) and "COPD" (1 trials). Many other conditions were trialed in "GPRI" in a lesser frequency.
Clinical Trials Intervention Types at GPRI
Most popular intervention types in "GPRI" are "Drug" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (1 trials), "NuvoAir platform" (1 trials), "Placebo" (1 trials), "Tirzepatide" (1 trials) and "VLA2001" (1 trials). Other intervention names were less common.
Clinical Trials Genders at GPRI
The vast majority of trials in "GPRI" are
6 trials for "All" genders.
Clinical Trials Status at GPRI
Currently, there are NaN active trials in "GPRI".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in GPRI,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in GPRI, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".